Answers are grounded in this paper and cite their sources.
Copper(I) complexes of methoxybis(2-pyridyl)(6-X-2-pyridyl)methane tripod ligands, where X is either methoxy, 4-t-butylphenoxy or 4-t-butylphenylsulfanyl substituent, were synthesized. The equilibrium between [Cu(ligand)]+, [Cu(ligand)2]+, solvated Cu+ ion and the metal-free ligand was examined by 1H NMR spectroscopy and cyclic voltammetry. These complexes reacted with carbon dioxide to give Cu(II) complexes.
No takes yet. Share an insight, caveat, or question.
Nagata et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: